A novel approach for establishing cardiovascular drug efficacy

doi:10.1038/nrd4090-c2

. 2014 Dec;13(12):942.

doi: 10.1038/nrd4090-c2. Epub 2014 Nov 14.

A novel approach for establishing cardiovascular drug efficacy

Hiddo J Lambers Heerspink¹, Diederick E Grobbee², Dick de Zeeuw¹

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.
² Julius Center for Health Science and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

PMID: 25398246
DOI: 10.1038/nrd4090-c2

A novel approach for establishing cardiovascular drug efficacy

Hiddo J Lambers Heerspink et al. Nat Rev Drug Discov. 2014 Dec.

. 2014 Dec;13(12):942.

doi: 10.1038/nrd4090-c2. Epub 2014 Nov 14.

Authors

Hiddo J Lambers Heerspink¹, Diederick E Grobbee², Dick de Zeeuw¹

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.
² Julius Center for Health Science and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

PMID: 25398246
DOI: 10.1038/nrd4090-c2

No abstract available

PubMed Disclaimer

Cited by

Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.
Schievink B, de Zeeuw D, Smink PA, Andress D, Brennan JJ, Coll B, Correa-Rotter R, Hou FF, Kohan D, Kitzman DW, Makino H, Parving HH, Perkovic V, Remuzzi G, Tobe S, Toto R, Hoekman J, Lambers Heerspink HJ. Schievink B, et al. Eur J Prev Cardiol. 2016 May;23(7):758-68. doi: 10.1177/2047487315598709. Epub 2015 Jul 30. Eur J Prev Cardiol. 2016. PMID: 26229089 Free PMC article. Clinical Trial.
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers.
Schievink B, de Zeeuw D, Parving HH, Rossing P, Lambers Heerspink HJ. Schievink B, et al. Br J Clin Pharmacol. 2015 Oct;80(4):678-86. doi: 10.1111/bcp.12655. Epub 2015 May 28. Br J Clin Pharmacol. 2015. PMID: 25872610 Free PMC article. Clinical Trial.
Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?
Hinder M, Yi BA, Langenickel TH. Hinder M, et al. Clin Pharmacol Ther. 2018 May;103(5):802-814. doi: 10.1002/cpt.1010. Epub 2018 Feb 1. Clin Pharmacol Ther. 2018. PMID: 29315510 Free PMC article. Review.
Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers.
Idzerda NMA, Stefansson BV, Pena MJ, Sjostrom DC, Wheeler DC, Heerspink HJL. Idzerda NMA, et al. Nephrol Dial Transplant. 2020 Sep 1;35(9):1570-1576. doi: 10.1093/ndt/gfz064. Nephrol Dial Transplant. 2020. PMID: 31005993 Free PMC article.
Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy.
de Zeeuw D, Heerspink HJL. de Zeeuw D, et al. Nephrol Dial Transplant. 2020 Mar 1;35(Suppl 2):ii38-ii42. doi: 10.1093/ndt/gfaa013. Nephrol Dial Transplant. 2020. PMID: 32162661 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A novel approach for establishing cardiovascular drug efficacy

Affiliations

A novel approach for establishing cardiovascular drug efficacy

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources